Anti-diabetic effects of brown algae derived phlorotannins, marine polyphenols through diverse mechanisms

Fitoterapia

Volumn 86, Issue 1, 2013, Pages 129-136

  Lee, Seung Hong ^a,c   Jeon, You Jin ^b  

^a Jeju National University School of Medicine   (South Korea)

^b Jeju National University   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Anti diabetic mechanisms; Brown algae; Marine polyphenols; Phlorotannins

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 6,6' BIECKOL; 7 PHLOROECKOL; ALPHA GLUCOSIDASE; AMYLASE; ANTIDIABETIC AGENT; DIECKOL; DIOXINODEHYDROECKOL; DIPHLORETHOHYDROXYCARMALOL; ECKOL; FUCODIPHLOROETHOL G; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; INSULIN; METFORMIN; NITRIC OXIDE; OCTAPHLORETHOL A; PEROXYNITRITE; PHLOROFUCOFUROECKOL A; PHLOROGLUCINOL; PHLOROTANNIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); POLYPHENOL; POLYPHENOL DERIVATIVE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; BROWN ALGA; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG STRUCTURE; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCATION; GLYCOGEN METABOLISM; HUMAN; HYPERGLYCEMIA; IC 50; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE ABSORPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; PHAEOPHYTA; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; TANNINS;

ALGAE; MUS; PHAEOPHYCEAE;

EID: 84876375175     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.02.013     Document Type: Review

References (51)

1. P. Zimmet, K. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787
2. A.D. Baron Postprandial hyperglycemia and α-glucosidase inhibitors Diabetes Res Clin Pract 40 1998 S51 S55
3. R.A. DeFronzo Pharmacologic therapy for type 2 diabetes mellitus Ann Intern Med 131 1999 281 303
4. M.S. Chang, M.S. Oh, D.R. Kim, K.J. Jung, S. Park, and S.B. Choi Effects of Okchun-San, a herbal formulation, on blood glucose levels and body weight in a model of type 2 diabetes J Ethnopharmacol 103 2006 491 495
5. U.J. Jung, N.I. Baek, H.G. Chung, M.H. Bang, J.S. Yoo, and T.S. Jeong The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice Food Chem Toxicol 45 2007 2022 2029
6. S.J. Heo, J.Y. Hwang, J.I. Choi, J.S. Han, H.J. Kim, and Y.J. Jeon Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent α-glucosidase and α-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice Eur J Pharmacol 615 2009 252 256
7. S.H. Lee, M.H. Park, S.J. Heo, S.M. Kang, S.C. KO, and J.S. Han Dieckol isolated from Ecklonia cava inhibits α-glucosidase and α-amylase in vitro, and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice Food Chem Toxicol 48 2010 2633 2637
8. S.H. Lee, J.S. Han, S.J. Heo, J.Y. Hwang, and Y.J. Jeon Protective effects of dieckol isolated from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells Toxicol In Vitro 24 2010 375 381
9. S.J. Heo, J.Y. Hwang, J.I. Choi, S.H. Lee, P.J. Park, and D.H. Kang Protective effect of diphlorethohydroxycarmalol isolated from Ishige okamurae against high glucose-induced-oxidative stress in human umbilical vein endothelial cells Food Chem Toxicol 48 2009 1448 1454
10. H.E. Moon, M.N. Islam, B.R. Ahn, S.S. Chowdhury, H.S. Sohn, and H.A. Jung Protein tyrosine phosphatase 1B and α-glucosidase inhibitory phlorotannins from edible brown algae, Ecklonia stolonifera and Eisenia bicyclis Biosci Biotechnol Biochem 75 2011 1472 1480
11. S.H. Lee, K.H. Min, J.S. Han, D.H. Lee, D.B. Park, and W.K. Jung Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus Food Chem Toxicol 50 2012 575 582
12. K.H. Min, H.J. Kim, Y.J. Jeon, and J.S. Han Ishige okamurae ameliorates hyperglycemia and insulin resistance in C57BL/KsJ-db/db mice Diabetes Res Clin Pract 93 2011 70 76
13. A.M.S. Mayer, and M.T. Hamann Marine Pharmacology in 2001-2002: marine compounds with antithelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action Comp Biochem Physiol C Toxicol Pharmacol 140 2005 265 286
14. S.J. Heo, J.P. Kim, W.K. Jung, N.H. Lee, H.S. Kang, and E.M. Jun Identification of chemical structure and free radical scavenging activity of diphlorethohydroxycarmalol isolated from a brown alga, Ishige okamurae J Microbiol Biotechnol 18 2008 676 681
15. C.S. Kong, J.A. Kim, N.Y. Yoon, and S.K. Kim Induction of apoptosis by phloroglucinol derivative from Ecklonia cava in MCF-7 human breast cancer cells Food Chem Toxicol 47 2009 1653 1658
16. E. Haslam, and Y. Cai Plant polyphenols (vegetable tannins): gallic acid metabolism Nat Prod Rep 11 1994 41 66
17. I.P. Singh, and S.B. Bharate Phloroglucinol compounds of natural origin Nat Prod Rep 23 2006 558 591
18. T.M. Arnold, and N.M. Targett Marine tannins: the importance of a mechanistic framework for predicting ecological roles J Chem Ecol 28 2002 1919 1934
19. M.A. Ragan, and K.W. Glombitza Phlorotannins, brown algal polyphenols J.A. Hellebust, J.S. Craigie, Progress in Phycological Research 1986 Cambridge University Press New York 129 241
20. S.H. Lee, Y. Li, F. Karadeniz, M.M. Kim, and S.K. Kim α-Glucosidase and α-amylase inhibitory activities of phloroglucinal derivatives from edible marine brown alga, Ecklonia cava J Sci Food Agric 89 2009 1552 1558
21. D.M. Gray Carbohydrate digestion and absorption role of small intestine N Engl J Med 29 1995 1225 1230
22. A.J. Krentz, and C.J. Bailey Oral antidiabetic agents. Current role in type 2 diabetes mellitus Drugs 65 2005 385 411
23. T. Matsui, T. Tanaka, S. Tamura, A. Toshima, Y. Miyata, and K. Tanaka Alpha-glucosidase inhibitory profile of catechins and theaflavins J Agric Food Chem 55 2007 99 105
24. H.E. Lebovitz Alpha-glucosidase inhibitors Endocrinol Metab Clin North Am 26 1997 539 551
25. Y. Hara, and M. Honda The inhibition of α-amylase by tea polyphenols Agric Biol Chem 54 1990 1939 1945
26. F. Nwosu, J. Morris, V.A. Lund, D. Stewart, H.A. Ross, and G.J. McDougall Anti-proliferative and potential anti-diabetic effects of phenolic-rich extracts from edible marine algae Food Chem 126 2011 1006 1012
27. J.L. Stern, A.E. Hagerman, P.D. Steinberg, and P.K. Mason Phlorotannins-protein interactions J Chem Ecol 22 1996 1877 1899
28. K.Y. Kim, K.A. Nam, H. Kurihara, and S.M. Kim Potent α-glucosidase inhibitors purified from the red alga Grateloupia elliptica Phytochemistry 69 2008 2820 2825
29. M.C. Roy, R. Anguenot, C. Fillion, M. Beaulieu, J. Berube, and D. Richard Effect of a commercially-available algal phlorotannins extract on digestive enzymes and carbohydrate absorption in vivo Food Res Int 44 2011 3026 3029
30. U. Ozcan, E. Yilmaz, L. Ozcan, M. Furuhashi, E. Vailancourt, and R.O. Smith Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes Science 313 2006 1137 1140
31. M. Cormont, J.F. Tanti, A. Zahraoui, E. Van Obberghen, A. Tavitian, and Y.L. Marchand-Brustel Insulin and okadaic acid induce Rab4 redistribution in adipocytes J Biol Chem 268 1993 19491 19497
32. M.J. Sheetz, and G.L. King Molecular understanding of hyperglycemia's adverse effects for diabetic complications J Am Med Assoc 288 2002 2579 2588
33. C.B. Dugani, V.K. Randhawa, A.W. Cheng, N. Patel, and A. Klip Selective regulation of the perinuclear distribution of glucose transport 4 (GLUT4) by insulin signals in muscle cells Eur J Cell Biol 87 2008 337 351
34. J. Harder, J. Bartels, E. Christophers, and J.M. Schroder Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic J Biol Chem 276 2001 5707 5713
35. P.A. Raj, and A.R. Dentino Current status of defensins and their role in innate and adaptive immunity FEMS Microbiol Lett 206 2002 9 18
36. U. Ozcan, Q. Cao, E. Yilmaz, A.H. Lee, N.N. Iwakoshi, and E. Ozdelen Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457 461
37. M.H. Zou, S.S. Kirkpatrick, B.J. Davis, J.S. Nelson, W.G. Wiles IV, and U. Schlattner Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo role of mitochondrial reactive nitrogen species J Biol Chem 279 2004 43940 43951
38. D. Konrad, A. Rudich, P.J. Bilan, N. Patel, C. Richardson, and L.A. Witters Troglitazone causes acute mitochondrial membrane depolarization and an AMPK-mediated increase in glucose phosphorylation in muscle cells Diabetologia 48 2005 954 956
39. C. Kang, Y.B. Jin, H. Lee, M. Cha, E. Sohn, and J. Moon Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways Food Chem Toxicol 48 2010 509 516
40. Guan J. Effect of dieckol from Ecklonia cava on glucose uptake in muscle cells and fat accumulation in liver cells. Master thesis, Jeju National University, Jeju, Korea; 2011.
41. S.H. Lee, S.M. Kang, S.C. Ko, D.H. Lee, and Y.J. Jeon Octaphlorethol A, a novel phenolic compound isolated from a brown alga, Ishige foliacea, increases glucose transporter 4-mediated glucose uptake in skeletal muscle cells Biochem Biophys Res Commun 420 2012 576 581
42. N.K. Tonks PTP1B: from the sidelines to the front lines! FEBS Lett 546 2003 140 148
43. S. Lee, and Q. Wang Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B Med Res Rev 27 2007 553 573
44. E. Shafrir Animal models of non-insulin-dependent diabetes Diabetes Metab Rev 8 1992 179 208
45. A. Basu, R. Basu, P. Shah, A. Vella, C.M. Johnson, and K.S. Nair Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: Additional evidence for a defect in hepatic glucokinase activity Diabetes 50 2001 1351 1362
46. C. Postic, M. Shiota, K.D. Niswender, T.L. Jetton, Y. Chen, and J.M. Moates Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β-cell-specific gene knock-outs using Cre recombinase J Biol Chem 274 1999 305 315
47. R.C. Nordlie, A.M. Bode, and J.D. Foster Recent advances in hepatic glucose-6-phosphate regulation and function Proc Soc Exp Biol Med 203 1993 274 285
48. G. Mithieux New knowledge regarding glucose-6-phosphatase gene and protein and their roles in the regulation of glucose metabolism Eur J Endocrinol 136 1997 137 145
49. G.F. Davies, R.L. Khandelwal, L. Wu, B.H. Juurlink, and W.J. Roesler Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferators-activated receptor-gamma (PPAR gamma)-independent, antioxidant-related mechanism Biochem Pharmacol 62 2001 1071 1079
50. T. Fujiwara, M. Wada, and K. Fukuda Characterization of CS-045, a new oral antidiabetic agent: I. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice Metabolism 40 1991 1213 1218
51. J. Patel, E. Miller, J. Hu, and J. Granett BRL 49653 (a thiazolidinedione) improves glycemic control in NIDDM patients Diabetes 46 1997 150A